- KR₩105bn
- -KR₩6bn
- KR₩150bn
- 80
- 95
- 37
- 84
Annual balance sheet for Ubiquoss, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 69,245 | 86,662 | 99,924 | 94,629 | 123,744 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,112 | 9,129 | 9,109 | 13,189 | 10,586 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 98,679 | 119,664 | 142,530 | 152,727 | 178,133 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,107 | 9,991 | 8,900 | 11,974 | 8,597 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 127,752 | 142,050 | 168,014 | 181,626 | 204,169 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 34,342 | 34,094 | 34,759 | 32,534 | 32,803 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 39,584 | 39,975 | 40,488 | 38,751 | 39,078 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 88,167 | 102,075 | 127,526 | 142,874 | 165,091 |
Total Liabilities & Shareholders' Equity | 127,752 | 142,050 | 168,014 | 181,626 | 204,169 |
Total Common Shares Outstanding |